XTrackers MSCI Thailand UCITS ETF 1C
| Issuer: Xtrackers |
| Asset Class: Equity |
| TER: 50bps |
| Trading Currency: USD |
| Pays Income: False |
| Listing Date: 12 Nov 2010 |
| Ticker: XCS4 |
| ISIN: LU0514694701 |
This investment vehicle offers targeted exposure to the Thai equity market, providing a convenient way to participate in the growth of a key Southeast Asian economy. Thailand's economy is notably diversified, with strong foundations in manufacturing, exports, and a world-renowned tourism sector. By investing in a portfolio of large and mid-capitalization companies, this fund captures the performance of the country's leading businesses across various key industries. It serves as a strategic tool for those looking to tap into the economic trajectory of one of the region's most established emerging markets.
The underlying portfolio is typically well-represented by sectors that form the backbone of the Thai economy. Financials, energy, and consumer staples often constitute significant weightings, reflecting the country's industrial activity and the consumption patterns of its large population. Additionally, sectors such as healthcare, real estate, and communication services are included, offering exposure to long-term domestic growth themes. This sectoral diversification allows investors to gain a comprehensive snapshot of the Thai market, balancing cyclical and defensive industries to navigate different economic environments.
Thailand's strategic location and role as a regional manufacturing hub present compelling long-term opportunities, further supported by government initiatives to advance the economy. However, potential investors should consider the associated risks inherent in a single-country emerging market investment. These can include currency fluctuations, political instability, and a high sensitivity to global economic cycles, particularly in relation to trade and tourism. A carefully considered allocation can allow for participation in Thailand's potential upside while managing these specific risks.